Literature DB >> 17626102

Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.

Rebecca L Skalsky1, Jianhong Hu, Rolf Renne.   

Abstract

Maintenance of Kaposi's sarcoma-associated herpesvirus (KSHV) episomes in latently infected cells is dependent on the latency-associated nuclear antigen (LANA). LANA binds to the viral terminal repeats (TR), leading to recruitment of cellular origin recognition complex proteins. Additionally, LANA tethers episomes to chromosomes via interactions with histones H2A and H2B (A. J. Barbera et al., Science 311:856-861, 2006). Despite these molecular details, less is known about how episomes are established after de novo infection. To address this, we measured short-term retention rates of green fluorescent protein-expressing replicons in proliferating lymphoid cells. In the absence of antibiotic selection, LANA significantly reduced the loss rate of TR-containing replicons. Additionally, we found that LANA can support long-term stability of KSHV replicons for more than 2 months under nonselective conditions. Analysis of cis elements within TR that confer episome replication and partitioning revealed that these activities can occur independently, and furthermore, both events contribute to episome stability. We found that replication-deficient plasmids containing LANA binding sites (LBS1/2) exhibited measurable retention rates in the presence of LANA. To confirm these observations, we uncoupled KSHV replication and partitioning by constructing hybrid origins containing the Epstein-Barr virus (EBV) dyad symmetry for plasmid replication and KSHV LBS1/2. We demonstrate that multiple LBS1/2 function in a manner analogous to that of the EBV family of repeats by forming an array of LANA binding sites for partitioning of KSHV genomes. Our data suggest that the efficiency with which KSHV establishes latency is dependent on multiple LANA activities, which stabilize viral genomes early after de novo infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626102      PMCID: PMC2045406          DOI: 10.1128/JVI.00842-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.

Authors:  Shuhei Sakakibara; Keiji Ueda; Ken Nishimura; Eunju Do; Eriko Ohsaki; Toshiomi Okuno; Koichi Yamanishi
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.

Authors:  J E Shaw; L F Levinger; C W Carter
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

Authors:  J Yates; N Warren; D Reisman; B Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin.

Authors:  William Stedman; Zhong Deng; Fang Lu; Paul M Lieberman
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.

Authors:  Eriko Ohsaki; Keiji Ueda; Shuhei Sakakibara; Eunju Do; Kaori Yada; Koichi Yamanishi
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 7.  Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease.

Authors:  Wolfgang Hammerschmidt; Bill Sugden
Journal:  Trends Mol Med       Date:  2004-07       Impact factor: 11.951

8.  Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Seung Min Yoo; Jian-Ping Xie; Philip J Browning; Shou-Jiang Gao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.

Authors:  E Cesarman; P S Moore; P H Rao; G Inghirami; D M Knowles; Y Chang
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

10.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.

Authors:  Ke Lan; Daniel A Kuppers; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  22 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Authors:  Rajesh Ponnusamy; Maxim V Petoukhov; Bruno Correia; Tania F Custodio; Franceline Juillard; Min Tan; Marta Pires de Miranda; Maria A Carrondo; J Pedro Simas; Kenneth M Kaye; Dmitri I Svergun; Colin E McVey
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

Review 3.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

5.  Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.

Authors:  Franceline Juillard; Erika De León Vázquez; Min Tan; Shijun Li; Kenneth M Kaye
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 6.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

7.  A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.

Authors:  Erika De León Vázquez; Franceline Juillard; Bernard Rosner; Kenneth M Kaye
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

8.  Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.

Authors:  Arundhati Gupta; Darby G Oldenburg; Eduardo Salinas; Douglas W White; J Craig Forrest
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

9.  Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Jianhong Hu; Eugene Liu; Rolf Renne
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Analysis of cis-elements that facilitate extrachromosomal persistence of human papillomavirus genomes.

Authors:  Daraporn Pittayakhajonwut; Peter C Angeletti
Journal:  Virology       Date:  2008-02-14       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.